Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (61-70 of 522) with videos related to

Pageof 53
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 8, 2022
Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!Niki Katsiki, Anca Pantea Stoian, Manfredi Rizzo
Diabetology & Metabolic Syndrome|December 22, 2022
Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagonsAntonio E Pontiroli, Manfredi Rizzo, Elena Tagliabue
Diabetes, Obesity & Metabolism|January 19, 2017
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetesManfredi Rizzo, Ali A Rizvi, Giorgio Sesti
Journal of Diabetes and Its Complications|March 5, 2023
Epicardial, peripancreatic and other "orthotopic" excessive fat deposition in south Asians and Europeans: Are differences clinically relevant?Niki Katsiki, Manfredi Rizzo, Dimitri P Mikhailidis
International Journal of Molecular Sciences|November 27, 2021
Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future AvenuesAli A Rizvi, Andrej Janez, Manfredi Rizzo
International Journal of Cardiology|March 18, 2019
Microvascular and macrovascular effects of liraglutideDomenico Cianflone, Ali A Rizvi, Manfredi Rizzo
Diabetes Research and Clinical Practice|April 20, 2020
COVID-19 and diabetes management: What should be considered?Antonio Ceriello, Anca Pantea Stoian, Manfredi Rizzo
Current Opinion in Cardiology|April 21, 2017
Small, dense LDL: an updatePhilipp A Gerber, Dragana Nikolic, Manfredi Rizzo
Current Medical Research and Opinion|September 19, 2014
Undertreatment of dyslipidemia: from the Arabian Gulf to the USA. Time to solve this problem!Vasilios G Athyros, Niki Katsiki, Manfredi Rizzo
Journal of Diabetes and Its Complications|February 10, 2023
Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patientsJelena Vekic, Anca Pantea Stoian, Manfredi Rizzo
Pageof 53

Showing results (61-70 of 522) with videos related to

Sort By:
Pageof 53
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 8, 2022
Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!Niki Katsiki, Anca Pantea Stoian, Manfredi Rizzo
Diabetology & Metabolic Syndrome|December 22, 2022
Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagonsAntonio E Pontiroli, Manfredi Rizzo, Elena Tagliabue
Diabetes, Obesity & Metabolism|January 19, 2017
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetesManfredi Rizzo, Ali A Rizvi, Giorgio Sesti
Journal of Diabetes and Its Complications|March 5, 2023
Epicardial, peripancreatic and other "orthotopic" excessive fat deposition in south Asians and Europeans: Are differences clinically relevant?Niki Katsiki, Manfredi Rizzo, Dimitri P Mikhailidis
International Journal of Molecular Sciences|November 27, 2021
Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future AvenuesAli A Rizvi, Andrej Janez, Manfredi Rizzo
International Journal of Cardiology|March 18, 2019
Microvascular and macrovascular effects of liraglutideDomenico Cianflone, Ali A Rizvi, Manfredi Rizzo
Diabetes Research and Clinical Practice|April 20, 2020
COVID-19 and diabetes management: What should be considered?Antonio Ceriello, Anca Pantea Stoian, Manfredi Rizzo
Current Opinion in Cardiology|April 21, 2017
Small, dense LDL: an updatePhilipp A Gerber, Dragana Nikolic, Manfredi Rizzo
Current Medical Research and Opinion|September 19, 2014
Undertreatment of dyslipidemia: from the Arabian Gulf to the USA. Time to solve this problem!Vasilios G Athyros, Niki Katsiki, Manfredi Rizzo
Journal of Diabetes and Its Complications|February 10, 2023
Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patientsJelena Vekic, Anca Pantea Stoian, Manfredi Rizzo
Pageof 53